Novacyt S.A. (EPA:ALNOV)
0.3840
-0.0035 (-0.90%)
Mar 13, 2026, 5:35 PM CET
Novacyt Market Cap
Novacyt has a market cap or net worth of €27.08 million as of March 13, 2026. Its market cap has decreased by -34.06% in one year.
Market Cap
27.08M
Enterprise Value
12.18M
Revenue
22.69M
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.38
Market Cap Chart
Since October 12, 2012, Novacyt's market cap has increased from 23.55M to 27.08M, an increase of 14.95%. That is a compound annual growth rate of 1.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 13, 2026 | 27.08M | -1.79% |
| Dec 31, 2025 | 27.57M | -35.08% |
| Dec 31, 2024 | 42.47M | -15.60% |
| Dec 29, 2023 | 50.32M | -42.02% |
| Dec 30, 2022 | 86.78M | -71.94% |
| Dec 31, 2021 | 309.30M | -55.31% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Median Technologies | 181.60M |
| Guerbet | 116.81M |
| Diagnostic Medical Systems | 33.15M |
| Implanet | 27.13M |
| Theraclion | 23.96M |
| Ikonisys | 23.13M |
| Mauna Kea Technologies | 20.68M |
| Biosynex | 16.20M |